Lysophosphatidylcholine augments Cav3.2 but not Cav3.1 T-type Ca2+ channel current expressed in HEK-293 cells

Pharmacology

Volumn 76, Issue 4, 2006, Pages 192-200

  Zheng, Mingqi ^a   Uchino, Tomoko ^a   Kaku, Toshihiko ^a   Kang, Lin ^a   Wang, Yan ^a   Takebayashi, Satoshi ^a   Ono, Katsushige ^a,b  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Lysophosphatidylcholine, electrophysiology; Protein kinase C; T type Ca2+ current

Indexed keywords

CALCIUM CHANNEL T TYPE; CHELERYTHRINE; LYSOPHOSPHATIDYLCHOLINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYO; ENZYME ACTIVITY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPERPOLARIZATION; KIDNEY CELL; NEWBORN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STEADY STATE;

ALKALOIDS; ANIMALS; ANIMALS, NEWBORN; BENZOPHENANTHRIDINES; CALCIUM CHANNELS, T-TYPE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHENANTHRIDINES; PROTEIN KINASE C; RATS; RATS, WISTAR;

EID: 33645963753     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092041     Document Type: Article

References (37)

1. Sedlis SP, Hom M, Sequeira JM, Esposito R: Lysophosphatidylcholine accumulation in ischemic human myocardium. J Lab Clin Med 1993;121:111-117.
2. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, Klein MS: Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 1978;62:546-553.
3. Corr PB, Cain ME, Witkowski FX, Price DA, Sobel BE: Potential arrhythmogenic electrophysiological derangements in canine Purkinje fibers induced by lysophosphoglycerides. Circ Res 1979;44:822-832.
4. Clarkson CW, Ten Eick RE: On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Circ Res 1983;52:543-556.
5. Nakaya H, Kimura S, Kanno M: Suppression of lysophosphatidylcholine-induced abnormal automaticity by verapamil in canine Purkinje fibers. Jpn J Pharmacol 1984;36:371-378.
6. + channels of guinea-pig ventricular myocytes. Cardiovasc Drugs Ther 1993;7:575-584.
7. Kiyosue T, Arita M: Effects of lysophosphatidylcholine on resting potassium conductance of isolated guinea pig ventricular cells. Pflügers Arch 1986;406:296-302.
8. Sato T, Kiyosue T, Arita M: Inhibitory effects of palmitoylcarnitine and lysophosphatidylcholine on the sodium current of cardiac ventricular cells. Pflügers Arch 1992;420:94-100.
9. Na via multiple protein kinase pathways. Circ Res 1997;81:387-395.
10. Undrovinas AI, Fleidervish IA, Makielski JC: Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 1992;71:1231-1241.
11. Corr PB, Snyder DW, Lee BI, Gross RW, Keim CR, Sobel BE: Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol 1982;243:H187-H195.
12. Snyder DW, Crafford WA Jr, Glashow JL, Rankin D, Sobel BE, Corr PB: Lysophosphoglycerides in ischemic myocardium effluent and potentiation of their arrhythmogenic effects. Am J Physiol 1981;241:H700-H707.
13. Giffin M, Arthur G, Choy PC, Man R: Lysophosphatidylcholine metabolism and cardiac arrhythmias. Can J Physiol Pharmacol 1988;66:185-189.
14. 2+ accumulation in rat cardiac myocytes. Am J Physiol 1983;244:H32-H38.
15. Woodley SL, Ikenouchi H, Barry WH: Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol 1991;23:671-680.
16. + stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidylcholine. Life Sci 1979;24:1869-1875.
17. Yu L, Netticadan T, Xu YJ, Panagia V, Dhalla NS: Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther 1998;286:1-8.
18. Yonemochi H, Yasunaga S, Teshima Y, Takahashi N, Nakagawa M, Ito M, Saikawa T: Rapid electrical stimulation of contraction reduces the density of β-adrenergic receptors and responsiveness of cultured neonatal rat cardiomyocytes: possible involvement of microtubule disassembly secondary to mechanical stress. Circulation 2000;101:2625-2630.
19. 2+ channel by bepridil. Pharmacology 2005;74:174-181.
20. 2+ channel currents. Am J Physiol Cell Physiol 2000;279:C603-C610.
21. Jiang LH, Gawler DJ, Hodson N, Milligan CJ, Pearson HA, Porter V, Wray D: Regulation of cloned cardiac L-type calcium channels by cGMP-dependent protein kinase. J Biol Chem 2000;275:6135-6143.
22. 2+ channel currents by calmodulin-dependent protein kinase II. Am J Physiol Cell Physiol 2000;279:C1694-C1703.
23. Ferron L, Capuano V, Ruchon Y, Deroubaix E, Coulombe A, Renaud JF: Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ Res 2003;93:1241-1248.
24. Perez-Reyes E: Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 2003;83:117-161.
25. Van den Bosch H: Phosphoglyceride metabolism. Annu Rev Biochem 1974;43:243-277.
26. Man RY, Lederman CL: Effect of reduced calcium on lysophosphatidylcholine-induced cardiac arrhythmias. Pharmacology 1985;31:11-16.
27. Sasaki Y, Asaoka Y, Nishizuka Y: Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids: subspecies differences. FEBS Lett 1993;320:47-51.
28. Tseng GN, Boyden PA: Different effects of intracellular Ca and protein kinase C on cardiac T and L Ca currents. Am J Physiol Heart Circ Physiol 1991;261:H364-H379.
29. Furukawa T, Ito H, Nitta J, Tsujino M, Adachi S, Hiroe M, Marumo F, Sawanobori T, Hiraoka M: Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ Res 1992;71:1242-1253.
30. Bassa BV, Roh DD, Vaziri ND, Kirschenbaum MA, Kamanna VS: Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCγ-1 and tyrosin kinase-Ras pathways. Am J Physiol Renal Physiol 1999;277:F328-F337.
31. 2+ channel currents by CaMKIIγc. J Physiol 2002;538:343-355.
32. 2+/calmodulin-dependent kinase II. J Neurosci 2003;23:10116-10121.
33. 2+ channel α1G. J Gen Physiol 2004;124:225-238.
34. Zhang Y, Cribbs LL, Satin J: Arachidonic acid modulation of α1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol 2000;278:H184-H193.
35. Shander GS, Undrovinas AI, Makielski JC: Rapid onset of lysophosphatidylcholine-induced modification of whole cell cardiac sodium kinetics. J Mol Cell Cardiol 1996;28:743-753.
36. Burnashev NA, Undrovinas AI, Fleidervish IA, Makielski JC, Rosenshtraukh LV: Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J Mol Cell Cardiol 1991;23(suppl 1):23-30.
37. DaTorre SD, Creer MH, Pogwizd SM, Corr PB: Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 1991;23(suppl 1):11-22.